Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Journal of Virology
|
February 6, 2025
Conformational activation and disulfide exchange in HIV-1 Env induce cell-free lytic/fusogenic transformation and enhance infection
Charles G Ang, Nadia L Hyatt, Giang Le Minh, et al.
Bioorganic & Medicinal Chemistry
|
July 8, 2011
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones
Elizabeth I Parkinson, M Jason Hatfield, Lyudmila Tsurkan, et al.
Cancer Research
|
August 3, 2005
Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan
Edyta Tyminski, Stanley Leroy, Kinya Terada, et al.
Bioorganic & Medicinal Chemistry
|
April 3, 2007
Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils
Latorya D Hicks, Janice L Hyatt, Teri Moak, et al.
Journal of Medicinal Chemistry
|
November 26, 2010
Structure-activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitors
Brandon M Young, Janice L Hyatt, David C Bouck, et al.
Gene Therapy
|
March 10, 2006
Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles
T L Fink, P J Klepcyk, S M Oette, et al.
Journal of Medicinal Chemistry
|
March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones
Janice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Molecular Pharmacology
|
March 18, 2005
The crystal structure of the complex of the anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica acetylcholinesterase provides a molecular explanation for its cholinergic action
Michal Harel, Janice L Hyatt, Boris Brumshtein, et al.
Molecular Pharmacology
|
December 15, 2006
Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compounds
Randy M Wadkins, Janice L Hyatt, Carol C Edwards, et al.
Cancer Chemotherapy and Pharmacology
|
May 27, 2005
Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice
Christopher L Morton, Lisa Iacono, Janice L Hyatt, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Journal of Virology
|
February 6, 2025
Conformational activation and disulfide exchange in HIV-1 Env induce cell-free lytic/fusogenic transformation and enhance infection
Charles G Ang, Nadia L Hyatt, Giang Le Minh, et al.
Bioorganic & Medicinal Chemistry
|
July 8, 2011
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones
Elizabeth I Parkinson, M Jason Hatfield, Lyudmila Tsurkan, et al.
Cancer Research
|
August 3, 2005
Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan
Edyta Tyminski, Stanley Leroy, Kinya Terada, et al.
Bioorganic & Medicinal Chemistry
|
April 3, 2007
Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils
Latorya D Hicks, Janice L Hyatt, Teri Moak, et al.
Journal of Medicinal Chemistry
|
November 26, 2010
Structure-activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitors
Brandon M Young, Janice L Hyatt, David C Bouck, et al.
Gene Therapy
|
March 10, 2006
Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles
T L Fink, P J Klepcyk, S M Oette, et al.
Journal of Medicinal Chemistry
|
March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones
Janice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Molecular Pharmacology
|
March 18, 2005
The crystal structure of the complex of the anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica acetylcholinesterase provides a molecular explanation for its cholinergic action
Michal Harel, Janice L Hyatt, Boris Brumshtein, et al.
Molecular Pharmacology
|
December 15, 2006
Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compounds
Randy M Wadkins, Janice L Hyatt, Carol C Edwards, et al.
Cancer Chemotherapy and Pharmacology
|
May 27, 2005
Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice
Christopher L Morton, Lisa Iacono, Janice L Hyatt, et al.
Page
of 6